Human Reproductive Technologies: Products and Global Markets

Published - Nov 2013| Analyst - Mary Anne Crandall| Code - HLC017D
Market Research Report Single User License: $3990

Report Highlights

The total market for reproductive technologies and products is estimated to achieve revenues of nearly $16.1 billion in 2013. In 2018, the forecasted revenues will likely reach $19.6 billion, demonstrating a compound annual growth rate (CAGR) of 4.1%.

Report Includes

  • An overview of the market for human reproductive technologies.
  • Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Examinations of market sizes in the categories of infertility, artificial reproductive technologies, fertility diagnostics, contraception, and sexual dysfunction, with a division of markets according to treatment type and indication.
  • Evaluations of pipeline products and technologies.
  • Patent analysis.

SCOPE OF STUDY

The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographic scope of the report is global. The report reviews male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores market size, identifies market participants and investigates pipeline products and technologies.

The global market for reproductive technologies and products is divided into categories by treatment type and indication as follows.

  • Infertility market—male and female factors, pharmaceuticals and future advancements.
    • IVF.
    • Assistive reproductive technologies. 
    • Fertility diagnostics.
  • Contraception—pharmaceuticals and devices.
  • Sexual dysfunction—pharmaceuticals and devices.

Each area is covered in detail, describing the disorder or treatment involved, identifying current products and treatments in the market in the base year 2013, measuring current market size and identifying current and potential market drivers, forecasting for 2018, assessing current and potential competitors and identifying current competitor market shares for the base year of 2013.

Analyst Credentials

BCC Research Analyst

Mary Anne Crandall is a medical research analyst and has specialized in the pharmaceuticals and medical device industry for the last 25 years. She has completed several in-depth studies on various medical topics requiring both expertise and knowledge of the industry. She is a retired nurse, has a B.S. and an M.S. in Psychology and is currently working on her Ph.D.

Select reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at(+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price
Full Report: Human Reproductive Technologies: Products and Global Markets 175 $3990
Chapter- 1: INTRODUCTION 3
Chapter- 2: SUMMARY 2 $250
Chapter- 3: INDUSTRY OVERVIEW 40 $1368
Chapter- 4: INFERTILITY MARKET 12 $410
Chapter- 5: METHODS OF TREATMENT 11 $376
Chapter- 6: ASSISTIVE REPRODUCTIVE TECHNOLOGIES 14 $479
Chapter- 7: FERTILITY DIAGNOSTICS 7 $239
Chapter- 8: CONTRACEPTION MARKET 27 $923
Chapter- 9: SEXUAL DYSFUNCTION MARKET 14 $479
Chapter- 10: PATENTS 2 $68
Chapter- 11: LEADING MARKET MANUFACTURERS 2 $68
Chapter- 12: TOTAL MARKET 9 $308
Chapter- 13: PARTICIPATING COMPANIES 9 $308
Chapter- 14: APPENDIX A 19 $650
Chapter- 15: APPENDIX B: LIST OF COMPANIES 4 $137
List of Tables
List of Figures
Download Table of Contents
RELATED REPORTS
Share This Report